The 3 Most Overhyped Marijuana Trends | The Motley Fool
What goes up must come down, right? Well, not if you're invested in the marijuana industry. Since the year began, the Horizons Marijuana Life Sciences ETF, which holds around four dozen pot stocks in various weightings, has risen by 63%, through March 5. Since April 2017, when this cannabis-focused exchanged-traded fund debuted, it's up nearly 110%.
It's no secret that investors and Wall Street are expecting big things from the legal pot industry. Cowen Group has aggressively called for $75 billion in global sales by 2030, with investment bank Jefferies projecting the industry could one day hit $130 billion in annual sales. But not every stock or every marijuana trend is necessarily going to be a success.
As I peruse the cannabis industry, I see three trends for 2019 that look to be overhyped. Should one or more of these trends fall flat, a period of reckoning could await pot stock investors.
Image source: Getty Images.
I'm not sure there's been a trend more overhyped since last summer than the expectation that cannabidiol (CBD)-based beverages were going to take off. CBD is the nonpsychoactive cannabinoid best known for its perceived medical benefits.Trending
- 3 Moneymaking Marijuana Trends for 2019 | The Motley Foolwww.fool.comDecember 29, 2018
- Reuters, Motley Fool, Street Register, and More Cover Medical Marijuana, Inc.’s Continued Growth - Medical Marijuana, Inc - Investorswww.medicalmarijuanainc.comMay 4, 2018
- Motley Fool: The Top 4 Cannabis Stocks in a Hot ETFinternationalcbc.comOctober 3, 2018
- Globalization of Cannabis: Trends & Opportunitiesmjbizconference.com